143 results
Page 6 of 8
425
plt10jf5vtu d9kf9iq
5 May 21
Business combination disclosure
5:24pm
6-K
m1qupm 0crq3
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.5
18h jciv55
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
pecen3e9
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
651uu we70v2fzx
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
j9vpi0 ji1k0r
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
vw8518fbe
30 Apr 21
Annual report (foreign)
12:53pm
20-F
EX-2.7
nmja8 mmyi58tfgla
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.6
527 86jz1vvm
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.1
uxnkf68737l
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.4
283dyz 3oqglxtmev
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.3
3wa544g 3l
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.2
ze49xhfu
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
6-K
EX-99.5
257hhx1
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
e7j6zerdov
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
oousr0twma4xxr
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
6-K
EX-99.1
petdl1l
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
cqi09ii2ltmzhh5
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
yb6s5klm
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
adzumhx6rbs9hl
8 Jan 21
Registration statement (foreign)
4:58pm